These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15604198)

  • 1. Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy.
    Bode L; Eklund EA; Murch S; Freeze HH
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1015-23. PubMed ID: 15604198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy.
    Bode L; Murch S; Freeze HH
    J Biol Chem; 2006 Mar; 281(12):7809-15. PubMed ID: 16434407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.
    Bode L; Salvestrini C; Park PW; Li JP; Esko JD; Yamaguchi Y; Murch S; Freeze HH
    J Clin Invest; 2008 Jan; 118(1):229-38. PubMed ID: 18064305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applied glycoproteomics--approaches to study genetic-environmental collisions causing protein-losing enteropathy.
    Bode L; Freeze HH
    Biochim Biophys Acta; 2006 Apr; 1760(4):547-59. PubMed ID: 16380211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation.
    Westphal V; Murch S; Kim S; Srikrishna G; Winchester B; Day R; Freeze HH
    Am J Pathol; 2000 Dec; 157(6):1917-25. PubMed ID: 11106564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands.
    Netelenbos T; van den Born J; Kessler FL; Zweegman S; Huijgens PC; Drager AM
    J Leukoc Biol; 2003 Dec; 74(6):1035-44. PubMed ID: 14525970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
    Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
    Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
    Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate proteoglycans and cancer.
    Blackhall FH; Merry CL; Davies EJ; Jayson GC
    Br J Cancer; 2001 Oct; 85(8):1094-8. PubMed ID: 11710818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier.
    Ye D; Ma I; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G496-504. PubMed ID: 16474009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of heparin therapy in protein-losing enteropathy associated with single ventricle palliation.
    Ryerson L; Goldberg C; Rosenthal A; Armstrong A
    Am J Cardiol; 2008 Jan; 101(2):248-51. PubMed ID: 18178416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
    Ostrow AM; Freeze H; Rychik J
    Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate.
    Dudás J; Ramadori G; Knittel T; Neubauer K; Raddatz D; Egedy K; Kovalszky I
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):245-51. PubMed ID: 10926850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression.
    Ma TY; Boivin MA; Ye D; Pedram A; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G422-30. PubMed ID: 15701621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
    Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.
    Hendriks J; Planelles L; de Jong-Odding J; Hardenberg G; Pals ST; Hahne M; Spaargaren M; Medema JP
    Cell Death Differ; 2005 Jun; 12(6):637-48. PubMed ID: 15846369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased leukocyte-endothelial interactions in syndecan-1-deficient mice involve heparan sulfate-dependent and -independent steps.
    Götte M; Bernfield M; Joussen AM
    Curr Eye Res; 2005 Jun; 30(6):417-22. PubMed ID: 16020273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of rat ventral prostate after castration involves heparanase-1.
    Augusto TM; Felisbino SL; Carvalho HF
    Cell Tissue Res; 2008 May; 332(2):307-15. PubMed ID: 18278514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opticin binds to heparan and chondroitin sulfate proteoglycans.
    Hindson VJ; Gallagher JT; Halfter W; Bishop PN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4417-23. PubMed ID: 16303928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.